Target intelligence / Profile preview

Endosomal and lysosomal membranes

Molecular classification
Other, Organelle membrane
01

Overview

The endosomal and lysosomal membranes are dynamic lipid bilayers that define the boundaries of the endolysosomal system, a critical network for cellular degradation, recycling, and signaling. These membranes maintain a highly acidic internal environment through the action of vacuolar H+-ATPases, which is essential for the function of over 60 different acid hydrolases responsible for breaking down macromolecules (Source: Nature Reviews Molecular Cell Biology, 2017). Beyond degradation, these membranes serve as essential platforms for nutrient sensing via the mTORC1 complex and regulate ion homeostasis, particularly calcium signaling (Source: Journal of Cell Science, 2018). In oncology, the integrity of the lysosomal membrane is a therapeutic vulnerability; inducing lysosomal membrane permeabilization (LMP) can release pro-apoptotic cathepsins into the cytosol to bypass traditional cell death resistance (Source: Cold Spring Harbor Perspectives in Biology, 2013). Conversely, in lysosomal storage disorders and neurodegenerative diseases like Parkinson's, membrane dysfunction due to lipid accumulation leads to impaired autophagy and toxic protein aggregation (Source: Lancet Neurology, 2018). Pharmacological modulation of these membranes includes the use of lysosomotropic agents like chloroquine, which alkalinize the lumen to inhibit viral entry and modulate immune responses, as well as small molecule chaperones that stabilize membrane-associated proteins (Source: Nature Reviews Drug Discovery, 2020).

Other names
Endolysosomal systemLysosomal membraneEndosomal membraneVacuolar membranesEndolysosomal compartment
02

Mechanism of action

Lysosomal membrane permeabilization (LMP), Endosomal pH modulation, Inhibition of endosome-lysosome fusion, Lipid composition modulation, Lysosomotropism

03

Biological functions

AutophagyEndocytosisProtein degradationNutrient sensingIon homeostasisSignal transduction
04

Disease associations

CancerNeurodegenerative diseaseInfectionLysosomal storage diseaseInflammation
05

Safety considerations

Drug-induced phospholipidosisSystemic toxicity due to ubiquitous lysosomal functionImpaired autophagic fluxOff-target organelle damage
06

Interacting drugs

Chloroquine

5 more in the full profile.

07

Biomarkers

Lysosome-associated membrane protein 1 (LAMP1)Lysosome-associated membrane protein 2 (LAMP2)Cytosolic Cathepsin B releaseGalectin-3 punctae formationLysoTracker staining intensity

Beyond the preview

Go deeper on Endosomal and lysosomal membranes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endosomal and lysosomal membranes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call